PAA 3.03% 17.0¢ pharmaust limited

Ann: Demonstration batch of smaller size MPL tablets completed, page-11

  1. 12,040 Posts.
    lightbulb Created with Sketch. 6155
    Afternoon @Gouldians , most of your interpretation is correct except MPL has always been for Human Cancer , Lymphoma to be exact.(but has been trialed on Ovarian and 140 other trials worldwide)

    The K9 Trials have been a necessary stepping stone as you are aware this is an Oral Treatment so taste, Palatability and Efficacy are crucial factors.

    I agree with you regarding the WEHI comment but Biolabs 360 is also based in Australia , Leiden did seem redundant but I was impressed they additionally assisted with Solubility.

    Been a critic of the slow pace and extremely poor messaging and plagued with delays BUT I'm here to make money and loads of it..

    This is no Same Same medicine with a different coloured label or gimmicky name, this is First In Class Medicine.. Only two other commercial MTOR pathway drugs that return their owners $2.53 Billion so market looks wide open from where I'm sitting and 420 SH own 82% of the company.. so when the value is recognised tight hands will see a rapid climb in SP..as only 18% is in the hands of Rats and Mice holdings.

    Best of luck with your other investments ,, many know I'm a fixed Margin Trader.. my Fixed margin here is 1000% the next time I'm selling will be just over the $1 range.. NZT

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.0¢
Change
0.005(3.03%)
Mkt cap ! $82.65M
Open High Low Value Volume
17.0¢ 18.0¢ 16.8¢ $151.1K 877.6K

Buyers (Bids)

No. Vol. Price($)
4 54714 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 371375 7
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.